- Bryon Petersen, University of Florida
- Xiangdong Wang, Fudan University
- Ulf Andersson Ørom, Max Planck Institute for Molecular Genetics
- Andrew Badley, Mayo Clinic and Foundation
- Marek Malecki, PBMEF
- Dan Peer, Tel Aviv University
Aims & scope
Molecular and Cellular Therapies is an online, open access journal which focusses on the basic science and clinical development of molecular and cell-based therapies.
The journal aligns basic research in the development of gene-, peptide-, protein-, and cell-based therapies with clinical and pre-clinical research, to establish new therapy parameters such as treatment pharmacokinetics, delivery, toxicity, efficacy, biomarkers and novel applications.
Xiangdong Wang, MD, PhD, is a Distinguished Professor of Respiratory Medicine at Fudan University, Deputy Director of Shanghai Respiratory Research Institute, and Adjunct Professor of Clinical Bioinformatics at Lund University. He also serves as a Director of the Biomedical Research Center at Zhongshan Hospital, Fudan University. His main research is focused on clinical bioinformatics, disease-specific biomarkers, cancer immunology, and molecular & cellular therapies.
Dr. Petersen received his BA from the University of Iowa, and received his MS and Ph.D. from the University of Pittsburgh. His post-doctorate training continued at Pitt in the Department of Pathology, and was promoted to Research Assistant Professor. In 2000 Dr. Petersen took a faculty position at the University of Florida as an Assistant Professor and was promoted to an Associate Professor with tenure. In 2010, he took a position at Wake Forest Institute of Regenerative Medicine. He returned to UF's Department of Pediatrics in July of 2012. He currently has authored or co-authored over 80 peer-reviewed papers and nine book chapters. He has been honored with several national and international awards and has secured NIH funding for the past 15 yrs.